Is IgM reliable for diagnosing anaplasmosis?

In a 77-year-old with suspected anaplasmosis, diagnostic interpretation should prioritize illness timing, exposure history, and treatment status over any isolated laboratory result. The three parts of the claim are well supported.

Clinical evidence

• IgM is not a reliable diagnostic marker. CDC guidance advises against using Anaplasma IgM as evidence of recent infection. Cross-reactivity between Anaplasma and Ehrlichia antibodies and persistence of seroreactivity make an isolated positive IgM non-confirmatory.
• Antibodies can persist well beyond recovery. A. phagocytophilum antibodies may remain elevated for months and, in some individuals, years (reported up to four years). Thus, a single elevated IgG titer may reflect previous infection or exposure rather than active disease.
• The preferred serologic evidence of recent infection is paired acute and convalescent IgG indirect fluorescent antibody testing showing a fourfold or greater rise in titer. Confirmed infections can seroconvert, but the timing and duration of antibody responses vary substantially.

PCR interpretation and mechanism

• Whole-blood PCR detects circulating bacterial DNA and is most useful in the first week of illness, before bacteremia declines. In a prospective study, sensitivity was approximately 74%, so false-negative results occur even under study conditions.
• Doxycycline can reduce PCR sensitivity within 48 hours; consequently, a negative result after treatment initiation, later in illness, or with low circulating organism burden cannot exclude infection.

Clinical implications

• Bottom line: The claim is accurate. Neither a positive IgM nor persistent antibody elevation establishes active anaplasmosis, and a negative PCR is not a definitive rule-out. When the clinical syndrome and exposure history are compatible, management should not be delayed or withheld solely because early PCR or serology is negative; acute PCR plus paired IgG serology provides the most informative diagnostic framework.